The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gentile Kimberly since 2017.
This trader's CIK number is 1704186.
At the time of last reporting, Gentile Kimberly was the SVP, Clinical Operations of Biohaven Ltd.. (stock ticker symbol BHVN).
Also see all insider trading activities at Biohaven Ltd..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | BHVN | 0 | $0 | 0 | $0 | 3,750 | $0 |
2021 | BHVN | 0 | $0 | 0 | $0 | 7,500 | $0 |
2020 | BHVN | 0 | $0 | 48,500 | $3,552,401 | 53,840 | $404,686 |
2019 | BHVN | 0 | $0 | 25,000 | $1,325,868 | 28,750 | $15,249 |
2018 | BHVN | 0 | $0 | 27,500 | $969,384 | 27,500 | $16,775 |
2017 | BHVN | 0 | $0 | 10,000 | $258,200 | 10,000 | $6,100 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | BHVN | 0 | $0 | 0 | $0 | 3,750 | $0 |
2022 | BHVN | 0 | $0 | 0 | $0 | 115,510 | $327,701 |
1. Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-01-06 | BHVN | Option Ex | 3,750 | .00 | 0 |
2021-11-25 | BHVN | Option Ex | 3,750 | .00 | 0 |
2021-01-06 | BHVN | Option Ex | 3,750 | .00 | 0 |
2020-11-25 | BHVN | Option Ex | 3,750 | .00 | 0 |
2020-10-08 | BHVN | Option Ex | 23,500 | 9.29 | 218,314 |
2020-10-08 | BHVN | Sale | 23,500 | 76.49 | 1,797,421 |
2020-06-17 | BHVN | Sale | 400 | 70.20 | 28,081 |
2020-06-17 | BHVN | Option Ex | 400 | 5.60 | 2,240 |
2020-06-17 | BHVN | Option Ex | 24,000 | 5.60 | 134,400 |
2020-06-17 | BHVN | Sale | 24,000 | 70.20 | 1,684,872 |
2020-06-08 | BHVN | Option Ex | 600 | 5.60 | 3,360 |
2020-06-08 | BHVN | Sale | 600 | 70.05 | 42,027 |
2020-01-09 | BHVN | Option Ex | 1,590 | 29.16 | 46,372 |
2019-12-18 | BHVN | Option Ex | 3,750 | .00 | 0 |
2019-11-20 | BHVN | Option Ex | 3,935 | .61 | 2,400 |
2019-11-21 | BHVN | Option Ex | 21,065 | .61 | 12,849 |
2019-11-20 | BHVN | Sale | 3,935 | 53.03 | 208,665 |
2019-11-21 | BHVN | Sale | 21,065 | 53.04 | 1,117,203 |
2018-06-15 | BHVN | Option Ex | 12,500 | .61 | 7,625 |
2018-06-15 | BHVN | Sale | 12,500 | 40.02 | 500,250 |
2018-03-01 | BHVN | Option Ex | 5,000 | .61 | 3,050 |
2018-03-01 | BHVN | Sale | 5,000 | 32.93 | 164,650 |
2018-02-01 | BHVN | Option Ex | 5,000 | .61 | 3,050 |
2018-02-01 | BHVN | Sale | 5,000 | 33.30 | 166,484 |
2018-01-02 | BHVN | Option Ex | 5,000 | .61 | 3,050 |
2018-01-02 | BHVN | Sale | 5,000 | 27.60 | 138,000 |
2017-12-01 | BHVN | Option Ex | 5,000 | .61 | 3,050 |
2017-12-01 | BHVN | Sale | 5,000 | 22.25 | 111,250 |
2017-11-01 | BHVN | Option Ex | 5,000 | .61 | 3,050 |
2017-11-01 | BHVN | Sale | 5,000 | 29.39 | 146,950 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-01-05 | BHVN | Option Ex | 3,750 | .00 | 0 |
2022-10-03 | BHVN | Option Ex | 115,510 | 2.84 | 327,701 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gentile Kimberly (SVP, Clinical Operations of Biohaven Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.